Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Tesla
TSLA
|
+$860M |
| 2 |
Amazon
AMZN
|
+$636M |
| 3 |
Microsoft
MSFT
|
+$586M |
| 4 |
AbbVie
ABBV
|
+$503M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$213M |
Top Sells
| 1 |
Home Depot
HD
|
+$282M |
| 2 |
Chevron
CVX
|
+$273M |
| 3 |
American Tower
AMT
|
+$188M |
| 4 |
ACC
American Campus Communities, Inc.
ACC
|
+$136M |
| 5 |
SAIL
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
|
+$99.7M |
Sector Composition
| 1 | Technology | 23.66% |
| 2 | Healthcare | 14.93% |
| 3 | Financials | 13.33% |
| 4 | Consumer Discretionary | 11.2% |
| 5 | Industrials | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMGN
1826
DELISTED
Immunogen Inc
IMGN
| $17.7M | ﹤0.01% |
3,707,278
+21,497
| +0.6% | +$103K |
|
|
SWTX
1827
DELISTED
SpringWorks Therapeutics
SWTX
| $17.7M | ﹤0.01% |
618,894
+61,230
| +11% | +$1.75M |
|
1828
PROS Holdings
PRO
$762M
| $17.7M | ﹤0.01% |
714,696
+18,834
| +3% | +$465K |
|
1829
FIGS
FIGS
$1.2B
| $17.6M | ﹤0.01% |
2,137,620
+780,126
| +57% | +$6.44M |
|
1830
Scorpio Tankers
STNG
$3.09B
| $17.6M | ﹤0.01% |
418,854
+4,297
| +1% | +$181K |
|
1831
Protolabs
PRLB
$1.18B
| $17.6M | ﹤0.01% |
482,920
+9,334
| +2% | +$340K |
|
1832
Allogene Therapeutics
ALLO
$251M
| $17.6M | ﹤0.01% |
1,628,667
+160,061
| +11% | +$1.73M |
|
1833
Emergent Biosolutions
EBS
$416M
| $17.6M | ﹤0.01% |
836,420
+4,469
| +0.5% | +$93.8K |
|
1834
Infosys
INFY
$73.3B
| $17.6M | ﹤0.01% |
1,034,667
-117,851
| -10% | -$2M |
|
1835
La-Z-Boy
LZB
$1.4B
| $17.5M | ﹤0.01% |
777,348
+25,209
| +3% | +$569K |
|
1836
Napco Security Technologies
NSSC
$1.53B
| $17.5M | ﹤0.01% |
603,051
+18,652
| +3% | +$542K |
|
1837
M/I Homes
MHO
$3.97B
| $17.5M | ﹤0.01% |
483,874
-695
| -0.1% | -$25.2K |
|
1838
Cogent Biosciences
COGT
$1.75B
| $17.5M | ﹤0.01% |
1,174,760
+436,836
| +59% | +$6.52M |
|
1839
Sturm, Ruger & Co
RGR
$635M
| $17.5M | ﹤0.01% |
343,966
+9,236
| +3% | +$469K |
|
1840
Dime Community Bancshares
DCOM
$1.35B
| $17.4M | ﹤0.01% |
595,544
-15,110
| -2% | -$442K |
|
1841
Surgery Partners
SGRY
$2.79B
| $17.4M | ﹤0.01% |
742,511
+34,492
| +5% | +$807K |
|
1842
Crinetics Pharmaceuticals
CRNX
$3.22B
| $17.3M | ﹤0.01% |
883,095
+32,157
| +4% | +$632K |
|
1843
Revolve Group
RVLV
$1.7B
| $17.3M | ﹤0.01% |
796,674
+26,273
| +3% | +$570K |
|
1844
Scholastic
SCHL
$683M
| $17.3M | ﹤0.01% |
561,568
+23,200
| +4% | +$714K |
|
1845
Utz Brands
UTZ
$1.07B
| $17.3M | ﹤0.01% |
1,143,083
+23,060
| +2% | +$348K |
|
1846
Gulfport Energy Corp
GPOR
$3.09B
| $17.2M | ﹤0.01% |
195,297
-7,441
| -4% | -$657K |
|
1847
Standex International
SXI
$2.54B
| $17.2M | ﹤0.01% |
210,995
+4,697
| +2% | +$383K |
|
|
KDNY
1848
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $17.2M | ﹤0.01% |
874,557
+44,483
| +5% | +$874K |
|
1849
First Foundation Inc
FFWM
$480M
| $17.2M | ﹤0.01% |
947,507
+37,537
| +4% | +$681K |
|
1850
Lemonade
LMND
$4.12B
| $17.1M | ﹤0.01% |
809,018
+124,219
| +18% | +$2.63M |
|